Incidence and prevalence of myelodysplastic syndromes: Data from the Düsseldorf MDS-registry

Leukemia Research

Volumn 35, Issue 12, 2011, Pages 1591-1596

  Neukirchen, Judith ^b   Schoonen, Wilma M ^a   Strupp, Corinna ^b   Gattermann, Norbert ^b   Aul, Carlo ^c   Haas, Rainer ^b   Germing, Ulrich ^b  

^a AMGEN LTD   (United Kingdom)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c ST JOHANNES HOSPITAL   (Germany)

Author keywords

Epidemiology; FAB; Incidence; Myelodysplastic syndromes; Prevalence; WHO

Indexed keywords

5Q- SYNDROME; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE CLASSIFICATION; DISEASE REGISTRY; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MYELODYSPLASTIC SYNDROME; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REFRACTORY ANEMIA; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS; REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA; REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA AND RINGED SIDEROBLASTS; SEX DIFFERENCE; STANDARDIZED INCIDENCE RATIO; TREND STUDY;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; FEMALE; GERMANY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PREVALENCE; REGISTRIES; RISK FACTORS;

EID: 80055110031     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.06.001     Document Type: Article

References (26)

1. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., et al. Proposals fort he classification of the myelodysplastic syndromes. Br J Haematol 1982, 51:189-199.
2. Bruning R., Orazi A., Germing U. Myelodysplastic syndromes/neoplasms. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 88. IARC Press, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele, J.W. Vardiman (Eds.).
3. Cole P., Sateren W., Delzell E. Epidemiologic perspectives on myelodysplastic syndromes and leukemia. Leukemia Res 1995, 19:361-365.
4. Germing U., Neukirchen J., Haas R. The epidemiology of myelodysplastic syndromes. Clin Leukemia 2008, 2:34-38.
5. Aul C., Gattermann N., Schneider W. Age-related incidence and other epidemiological aspects of myelodysplastic syndromes. Br J Haematol 1992, 82:358-367.
6. Germing U., Strupp C., Kundgen A., Bowen D., Aul C., Haas R., et al. No increase in age-specific incidence of myelodysplastic syndromes. Haematologica 2004, 89:905-910.
7. Gologan R., Georgescu D., Tatic A., Radulescu I., Vasilache D. Epidemiological data from the registry of patients with myelodysplastic syndrome in a single hospital center of Romania. Leukemia Res 2009, 33:1556-1561.
8. Iglesias Gallego M., Sastre Moral J.L., Gayoso Diz P., Garcia Costa A., Ros Forteza S., Mayan Santos J.M. Incidence and characteristics of myelodysplastic syndromes in Ourense (Spain) between 1994 and 1998. Haematologica 2003, 88:1197-1199.
9. Ma X., Does M., Raza A., Mayne S.T. Myelodysplastic syndromes: incidence and survival in the United States. Cancer 2007, 109:1536-1542.
10. Maynadie M., Verret C., Moskovtchenko P., Mugneret F., Petrella T., Caillot D., et al. Epidemiological characteristics of myelodysplastic syndrome in a well-defined French population. Br J Cancer 1996, 74:288-290.
11. Phekoo K.J., Richards M.A., Moller H., Schey S.A. The incidence and outcome of myeloid malignancies in 2112 adult patients in southeast England. Haematologica 2006, 91:1400-1404.
12. Rollison D.E., Howlader N., Smith M.T., Strom S.S., Merritt W.D., Ries L.A., et al. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood 2008, 112:45-52.
13. Troussard X., Duchenet V., Cornet E., Mouchel D., Malet M., Collignon A. Haematological malignancies: incidence in Basse-Normandie France, for 1997-2004. Rev Epidemiol Sante Publique 2009, 57:151-158.
14. Williamson P.J., Krueger A.R., Reynolds P.J., Hamblin T.J., Oscier D.G. Establishing the incidence of myelodysplastic syndromes. Br J Haematol 1994, 87:743-745.
15. Cartwright R.A., Gilman E.A., Gurney K.A. Time trends in incidence of haematological malignancies and related conditions. Br J Haematol 1999, 106:281-295.
16. Information und Technik Nordrhein-Westfalen. [accessed on 8.06.2010]. http://www.it.nrw.de/.
17. Fenaux P. Response assessments in low-risk and high-risk myelodysplastic syndromes (MDS). Semin Oncol 2005, 32:11-15.
18. Komrokji R.S., Bennett J.M. Evolving classifications of the myelodysplastic syndromes. Curr Opin Hematol 2007, 14:98-105.
19. Kirkwood B.R., Sterne A.C. Longitudinal studies rates and the Poisson distribution. Essential Medical Statistics 2003, Blackwell Science Ltd, Oxford, 238. B. Kirkwood, A.C. Sterne (Eds.).
20. Germing U., Aul C., Niemeyer C.M., Haas R., Bennett J.M. Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes. Ann Hematol 2008, 87:691-699.
21. Wilson E.B. Probable inference, the law of succession, and statistical inference. J Am Statist Assoc 1927, 22:209-212.
22. Breslow N.E., Day N.E. Rates and rate standardization. Statistical methods in cancer research 1987, 49-79. IARC Scientific Publications, Lyon. E. Heseltine (Ed.).
23. Ahmad OE, Boschi-Pinto C, Lopez AD, Murray CJL, Lozarno R, Inoue M. Age standardization of rates: a new WHO standard. In: GPE discussion paper. Geneva: World Health Organization; 2000. Series No. 31.
24. Eurostat population data. [accessed on 8.06.2010]. http://epp.eurostat.ec.europa.eu/portal/page/portal/population/data/database.
25. Matsuda A., Germing U., Jinnai I., Misumi M., Kuendgen A., Knipp S., et al. Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes. Blood 2005, 106:2633-2640.
26. Cartwrigt R.A., Gurney K.A., Moorman A.V. Sex ratios and the risks of haematological malignancies. Br J Haematol 2002, 118:1071-1077.